用友網絡(600588.SH)擬1500萬美元認購用友海外發展公司3萬股新股
格隆匯11月25日丨用友網絡(600588.SH)公佈,為促進海外業務拓展,公司擬增加對用友海外發展公司的投資,投資額1500萬美元。具體方案如下:公司計劃認購用友海外發展公司增發的3萬股新股,認購價格為每股500美元。新股增發後,用友海外發展公司註冊資本金為2398萬美元,公司持有其100%的股權。本次投資符合公司戰略發展要求,對用友3.0戰略目標的實現具有積極意義。
截止2019年9月30日,用友海外發展公司資產總額為人民幣9367.83萬元、負債總額為人民幣4513.30萬元、所有者權益總額為人民幣4854.52萬元、營業收入為人民幣5684.1951萬元、淨利潤為人民幣136.5973萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.